Related references
Note: Only part of the references are listed.Bone morphogenetic protein receptor signal transduction in human disease
Maria Catalina Gomez-Puerto et al.
JOURNAL OF PATHOLOGY (2019)
Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction
Xianyuan Lu et al.
PHYTOMEDICINE (2019)
Macrophages: versatile players in renal inflammation and fibrosis
Patrick Ming-Kuen Tang et al.
NATURE REVIEWS NEPHROLOGY (2019)
LRNA9884, a Novel Smad3-Dependent Long Noncoding RNA, Promotes Diabetic Kidney Injury in db/db Mice via Enhancing MCP-1-Dependent Renal Inflammation
Ying-ying Zhang et al.
DIABETES (2019)
Livin is involved in TGF-β1-induced renal tubular epithelial-mesenchymal transition through lncRNA-ATB
Jieqing Zhou et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Gene expression profiling analysis reveals that the long non-coding RNA uc.412 is involved in mesangial cell proliferation
Minyi Yu et al.
MOLECULAR MEDICINE REPORTS (2019)
LncRNA ENST00000453774.1 contributes to oxidative stress defense dependent on autophagy mediation to reduce extracellular matrix and alleviate renal fibrosis
Xiangcheng Xiao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Exosome-Mediated miR-29 Transfer Reduces Muscle Atrophy and Kidney Fibrosis in Mice
Haidong Wang et al.
MOLECULAR THERAPY (2019)
Krνppel-like factors (KLFs) in renal physiology and disease
Madhavi J. Rane et al.
EBIOMEDICINE (2019)
Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale
Michele Provenzano et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Long non-coding RNAs: An essential emerging field in kidney pathogenesis
Hakimeh Moghaddas Sani et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment
Lin Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
TGF-β1/p53 signaling in renal fibrogenesis
Stephen P. Higgins et al.
CELLULAR SIGNALLING (2018)
The preventive and therapeutic implication for renal fibrosis by targetting TGF-β/Smad3 signaling
Yun Zhang et al.
CLINICAL SCIENCE (2018)
Transforming growth factor-β signalling in renal fibrosis: from Smads to non-coding RNAs
Patrick Ming-Kuen Tang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2018)
TGF-β Mediates Renal Fibrosis via the Smad3-Erbb4-IR Long Noncoding RNA Axis
Min Feng et al.
MOLECULAR THERAPY (2018)
Transforming Growth Factor-β1/Smad7 in intestinal immunity, inflammation, and Cancer
Edoardo Troncone et al.
FRONTIERS IN IMMUNOLOGY (2018)
Preparation and evaluation of anti-renal fibrosis activity of novel truncated TGF- receptor type II
Haifeng Liu et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2018)
Targeting TGF-β Signaling in Kidney Fibrosis
Yoshitaka Isaka
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome
Simona E. Mihai et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Long noncoding RNA lnc-TSI inhibits renal fibrogenesis by negatively regulating the TGF-β/Smad3 pathway
Peng Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-β1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy
Na Du et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Loss of Smad7 Promotes Inflammation in Rheumatoid Arthritis
Gengmin Zhou et al.
FRONTIERS IN IMMUNOLOGY (2018)
FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy
Ivonne Loeffler et al.
CELL AND TISSUE RESEARCH (2018)
Novel lncRNA Erbb4-IR Promotes Diabetic Kidney Injury in db/db Mice by Targeting miR-29b
Si F. Sun et al.
DIABETES (2018)
FGF23 promotes renal interstitial fibrosis by activating beta-catenin
Q. Zhu et al.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES (2018)
Anti-TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
James Voelker et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Signaling Cross Talk between TGF-beta/Smad and Other Signaling Pathways
Kunxin Luo
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Regulation of TGF-β Family Signaling by Inhibitory Smads
Keiji Miyazawa et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Role of endothelial-to-mesenchymal transition induced by TGF-β1 in transplant kidney interstitial fibrosis
Zijie Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Transforming growth factor- activated long non-coding RNA ATB plays an important role in acute rejection of renal allografts and may impacts the postoperative pharmaceutical immunosuppression therapy
Jiang Qiu et al.
NEPHROLOGY (2017)
Transcriptome Identified lncRNAs Associated with Renal Fibrosisin UUO Rat Model
Jiazeng Sun et al.
FRONTIERS IN PHYSIOLOGY (2017)
Chronic kidney disease
Paola Romagnani et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA
Iain M. Dykes et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2017)
Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
Lisa H. Lancaster et al.
EUROPEAN RESPIRATORY REVIEW (2017)
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis
Flavio Vincenti et al.
KIDNEY INTERNATIONAL REPORTS (2017)
Inflammation drives renal scarring in experimental pyelonephritis
Birong Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-beta (TGF-beta/Smad Signaling
Xiaohua Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog
Maria Edeling et al.
NATURE REVIEWS NEPHROLOGY (2016)
The epidermal growth factor receptor pathway in chronic kidney diseases
Laura R. Harskamp et al.
NATURE REVIEWS NEPHROLOGY (2016)
The global burden of chronic kidney disease: estimates, variability and pitfalls
Richard J. Glassock et al.
Nature Reviews Nephrology (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
The Changing Landscape of Renal Inflammation
Thomas Ernandez et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Long non-coding RNA-H19 antagonism protects against renal fibrosis
Hong Xie et al.
ONCOTARGET (2016)
Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats
TingTing Zhao et al.
PLOS ONE (2016)
TGF-β signaling in the kidney: profibrotic and protective effects
Angara Sureshbabu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7
Aaron D. McClelland et al.
CLINICAL SCIENCE (2015)
The Smad3/Smad4/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction
Xinli Qu et al.
KIDNEY INTERNATIONAL (2015)
Long Noncoding RNA Arid2-IR Is a Novel Therapeutic Target for Renal Inflammation
Qin Zhou et al.
MOLECULAR THERAPY (2015)
TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?
Jose M. Munoz-Felix et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Ubiquitination and regulation of Smad7 in the TGF-β1/Smad signaling of aristolochic acid nephropathy
Yahui Tian et al.
TOXICOLOGY MECHANISMS AND METHODS (2015)
Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin
Xiao-ming Meng et al.
ONCOTARGET (2015)
Smad7 protects against chronic aristolochic acid nephropathy in mice
Xiao-Yu Dai et al.
ONCOTARGET (2015)
Ubiquitination and regulation of Smad7 in the TGF-β1/Smad signaling of aristolochic acid nephropathy
Yahui Tian et al.
TOXICOLOGY MECHANISMS AND METHODS (2015)
MicroRNAs in renal fibrosis
Arthur C. -K. Chung et al.
FRONTIERS IN PHYSIOLOGY (2015)
MicroRNA-21 in Glomerular Injury
Jennifer Y. Lai et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Identification of Novel Long Noncoding RNAs Associated with TGF-β/Smad3-Mediated Renal Inflammation and Fibrosis by RNA Sequencing
Qin Zhou et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Opposing Roles for Smad2 and Smad3 in Peritoneal Fibrosis in Vivo and in Vitro
Wen-Juan Duan et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Effects of astragalus injection on the TGFβ/Smad pathway in the kidney in type 2 diabetic mice
Yanna Nie et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension
Guan-Xian Liu et al.
CLINICAL SCIENCE (2014)
Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo
Yi-Gang Wan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2014)
Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b
Bo Wang et al.
KIDNEY INTERNATIONAL (2014)
MicroRNA-29b inhibits peritoneal fibrosis in a mouse model of peritoneal dialysis
Jian-Wen Yu et al.
LABORATORY INVESTIGATION (2014)
MicroRNA-29b Inhibits Diabetic Nephropathy in db/db Mice
Hai-Yong Chen et al.
MOLECULAR THERAPY (2014)
miR-29b as a Therapeutic Agent for Angiotensin II-induced Cardiac Fibrosis by Targeting TGF-β/Smad3 signaling
Yang Zhang et al.
MOLECULAR THERAPY (2014)
Inflammatory processes in renal fibrosis
Xiao-Ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2014)
siRNAs targeted to Smad4 prevent renal fibrosis in vivo
Yoshiyuki Morishita et al.
SCIENTIFIC REPORTS (2014)
Macrophages promote renal fibrosis through direct and indirect mechanisms
David J. Nikolic-Paterson et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2014)
miR-21-Containing Microvesicles from Injured Tubular Epithelial Cells Promote Tubular Phenotype Transition by Targeting PTEN Protein
Yang Zhou et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases
Yong He et al.
BIOCHIMIE (2013)
Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species
Rohan Samarakoon et al.
CELLULAR SIGNALLING (2013)
Role of the TGF-β/BMP-7/Smad pathways in renal diseases
Xiao-Ming Meng et al.
CLINICAL SCIENCE (2013)
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes
X. Zhong et al.
DIABETOLOGIA (2013)
Meeting report - TGF-β superfamily: signaling in development and disease
Ying E. Zhang et al.
JOURNAL OF CELL SCIENCE (2013)
The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway
Rong Li et al.
KIDNEY INTERNATIONAL (2013)
Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs
Arthur C. K. Chung et al.
MOLECULAR THERAPY (2013)
Increased Circulating miR-21 Levels Are Associated with Kidney Fibrosis
Francois Glowacki et al.
PLOS ONE (2013)
Disruption of Smad7 Promotes ANG II-Mediated Renal Inflammation and Fibrosis via Sp1-TGF-β/Smad3-NF•κB-Dependent Mechanisms in Mice
Guan-Xian Liu et al.
PLOS ONE (2013)
MicroRNA and nephropathy: emerging concepts
Arthur C. K. Chung et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE (2013)
MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis
Lin-Li Lv et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Role of TGF-beta in chronic kidney disease: an integration of tubular, glomerular and vascular effects
Francisco J. Lopez-Hernandez et al.
CELL AND TISSUE RESEARCH (2012)
Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice
S. M. Ka et al.
DIABETOLOGIA (2012)
Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro
Xiao-Ming Meng et al.
JOURNAL OF PATHOLOGY (2012)
Suppression of microRNA-29 Expression by TGF-β1 Promotes Collagen Expression and Renal Fibrosis
Bo Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro
Xiao-Ming Meng et al.
KIDNEY INTERNATIONAL (2012)
TGFβ signalling in context
Joan Massague
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury
Alison J. Kriegel et al.
PHYSIOLOGICAL GENOMICS (2012)
MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways
B. Nelson Chau et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
TGF-β/Smad Signaling in Kidney Disease
Hui Y. Lan et al.
SEMINARS IN NEPHROLOGY (2012)
Smad3 mediates ANG II-induced hypertensive kidney disease in mice
Zhen Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling
Xiaohua Yan et al.
BIOCHEMICAL JOURNAL (2011)
The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential
Hai Yong Chen et al.
DIABETES (2011)
Diverse Roles of TGF-beta/Smads in Renal Fibrosis and Inflammation
Hui Yao Lan
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29
Wei Qin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Pirfenidone for Diabetic Nephropathy
Kumar Sharma et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Smad3-Mediated Upregulation of miR-21 Promotes Renal Fibrosis
Xiang Zhong et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
Howard Trachtman et al.
KIDNEY INTERNATIONAL (2011)
Cellular and molecular mechanisms of renal fibrosis
Youhua Liu
NATURE REVIEWS NEPHROLOGY (2011)
Identification of a microRNA signature in renal fibrosis: role of miR-21
Abolfazl Zarjou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Blockade of Endothelial-Mesenchymal Transition by a Smad3 Inhibitor Delays the Early Development of Streptozotocin-Induced Diabetic Nephropathy
Jinhua Li et al.
DIABETES (2010)
BMP-7 as antagonist of organ fibrosis
Ralf Weiskirchen
Frontiers in Bioscience-Landmark (2010)
Advanced Glycation End-Products Induce Tubular CTGF via TGF-β-Independent Smad3 Signaling
Arthur C. K. Chung et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
miR-192 Mediates TGF-β/Smad3-Driven Renal Fibrosis
Arthur C. K. Chung et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Smad2 Protects against TGF-β/Smad3-Mediated Renal Fibrosis
Xiao Ming Meng et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
NF-κB in Renal Inflammation
Ana Belen Sanz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
miR-200b Precursor Can Ameliorate Renal Tubulointerstitial Fibrosis
Shigeyoshi Oba et al.
PLOS ONE (2010)
Mechanism of chronic aristolochic acid nephropathy: role of Smad3
Li Zhou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Regulation of TGF-beta signaling by Smad7
Xiaohua Yan et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2009)
Angiotensin II Induces Connective Tissue Growth Factor and Collagen I Expression via Transforming Growth Factor-β-Dependent and -Independent Smad Pathways The Role of Smad3
Fuye Yang et al.
HYPERTENSION (2009)
TGF-β:: A master of all T cell trades
Ming O. Li et al.
CELL (2008)
Smad7 as a therapeutic agent for chronic kidney diseases
Hui Yao Lan
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Latent TGF-β1 protects against crescentic glornerulonephritis
Xiao R. Huang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Arkadia regulates TGF-β signaling during renal tubular epithelial to mesenchymal cell transition
F-Y Liu et al.
KIDNEY INTERNATIONAL (2008)
Mice overexpressing latent TGF-β1 are protected against renal fibrosis in obstructive kidney disease
Xiao R. Huang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
The structure of the TGF-beta latency associated peptide region determines the ability of the proprotein convertase furin to cleave TGF-beta s
Makoto Kusakabe et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis
Monique E. Cho et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice
Shuk-Man Ka et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
An expanded WW domain recognition motif revealed by the interaction between Smad7 and the E3 ubiquitin ligase Smurf2
P. Andrew Chong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Essential role of Smad3 in angiotensin II-induced vascular fibrosis
WS Wang et al.
CIRCULATION RESEARCH (2006)
Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation
WJ Ju et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Signaling mechanism of TGF-βl in prevention of renal inflammation:: Role of Smad7
WS Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Blockade of NFκB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney
YY Ng et al.
KIDNEY INTERNATIONAL (2005)
Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-β signaling and fibrosis in rat remnant kidney
CC Hou et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Transforming growth factor-β and Smad signalling in kidney diseases
WS Wang et al.
NEPHROLOGY (2005)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Role of Smad4 on TGF-β-induced extracellular matrix stimulation in mesangial cells
K Tsuchida et al.
KIDNEY INTERNATIONAL (2003)
Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model
HY Lan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-β1
MC Hall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Making sense of latent TGFβ activation
JP Annes et al.
JOURNAL OF CELL SCIENCE (2003)
Reversibility of established diabetic glomerulopathy by anti-TGF-β antibodies in dbldb mice
S Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Smad7 inhibits fibrotic effect of TGF-β on renal tubular epithelial cells by blocking Smad2 activation
JH Li et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation
T Ebisawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Antibody to transforming growth factor-β ameliorates tubular apoptosis in unilateral ureteral obstruction
A Miyajima et al.
KIDNEY INTERNATIONAL (2000)
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice
FN Ziyadeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)